tiprankstipranks
Trending News
More News >
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics (ALLR) Income Statement

Compare
367 Followers

Allarity Therapeutics Income Statement

Last quarter (Q3 2025), Allarity Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Allarity Therapeutics's net income was $-2.81M. See Allarity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 27.24M$ 17.13M$ 34.46M$ 26.56M$ 8.32M
Depreciation and Amortization
$ 9.00K$ 37.00K$ 60.00K$ 106.00K$ 86.00K
EBITDA
$ -24.23M$ -11.28M$ -17.30M$ -25.77M$ -6.01M
Operating Income
$ -27.24M$ -17.13M$ -34.46M$ -26.56M$ -8.32M
Other Income/Expenses
$ 2.35M$ 5.31M$ 16.88M$ 41.00K$ 1.90M
Pretax Income
$ -24.90M$ -11.82M$ -17.58M$ -26.52M$ -6.42M
Net Income
$ -24.52M$ -11.90M$ -16.06M$ -26.65M$ -6.60M
Per Share Metrics
Basic EPS
$ -15.79$ -6.15K$ -1.86M$ -3.52M$ -1.70M
Diluted EPS
$ -15.79$ -6.15K$ -1.86M$ -3.52M$ -1.70M
Weighted Average Shares Outstanding
1.61M 3.32K---
Weighted Average Shares Outstanding (Diluted)
1.61M 3.32K---
Currency in USD

Allarity Therapeutics Earnings and Revenue History